Wilson Sonsini Goodrich & Rosati advised Borealis Biosciences on the transaction. Borealis Biosciences (Borealis), a next-generation RNA medicines company, emerged from stealth with $150 million in...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Sana Biotechnology on the offering, and Cooley advised the underwriters. Sana Biotechnology, Inc. (Nasdaq: SANA) announced the closing of its...
You must be a Standard 1 Year member to access this content.
Cooley advised Ionis Pharmaceuticals on the offering. Ionis Pharmaceuticals, a biotechnology company, announced the offering of $575 million aggregate principal amount of convertible senior notes, including the exercise...
You must be a Standard 1 Year member to access this content.
Cooley LLP and Conyers advised Origin, while Cleary Gottlieb Steen & Hamilton LLP advised Artius on the deal. Artius Acquisition, a “special purpose acquisition corporation” (SPAC),...
You must be a Standard 1 Year member to access this content.
